#AANAM – Trial Will Evaluate Tofersen in Presymptomatic SOD1 Patients

#AANAM – Trial Will Evaluate Tofersen in Presymptomatic SOD1 Patients

292718

#AANAM – Trial Will Evaluate Tofersen in Presymptomatic SOD1 Patients

Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. A new clinical trial will seek to determine the optimal timing to begin treatment with the investigational medication tofersen in people who have SOD1 gene mutations, but who do not yet have clinically manifest amyotrophic lateral sclerosis (ALS). The ATLAS trial is expected to start in the coming months at…

You must be logged in to read/download the full post.